Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000464 · ClinicalTrials.gov registry record · NA

Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer

A NA study of Prostate Cancer, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT04000464 is a NA study of Prostate Cancer that has completed, run by University of Arizona. The registered enrollment target is 31 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000464, a NA study of Prostate Cancer, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This study is an investigator initiated clinical study. A prospective, single arm unblinded, open label study will be carried out to determine the feasibility of recruitment, retention and adherence of 30 prostate cancer survivors who have been on androgen deprivation therapy within the last 5 years for a lifestyle modification intervention.

Conditions Studied

Interventions

  • BEHAVIORAL CLIPP

Study Locations (1)

Arizona

  • University of Arizona School of Medicine Collaboratory - Tucson

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2018-10-09
Est. Completion 2019-12-30
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT04000464

The ClinicalTrials.gov registry entry for NCT04000464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which CLIPP is the first listed.

NCT04000464 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT04000464 about?

NCT04000464 is a clinical study titled "Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer". This study is an investigator initiated clinical study. A prospective, single arm unblinded, open label study will be carried out to determine the feasibility of recruitment, retention and adherence of 30 prostate cancer survivors who have been on androgen deprivation therapy within the last 5 years...

What is the current status of trial NCT04000464?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-10-09. Estimated completion is 2019-12-30.

What conditions does trial NCT04000464 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04000464?

The interventions under investigation include: CLIPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT04000464?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04000464 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.